U.S. CRISPR And Cas Genes Market Size, Share & Trends Analysis Report By Product & Service, By Application (Biomedical, Agricultural), By End-use (Biotechnology & Pharmaceutical Companies), And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product& Service
                        1.2.2. Application
                        1.2.3. End-use
                        1.2.4. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in Italy
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Product& Service
                        2.2.2. Application
                        2.2.3. End-use
                    2.3. Competitive Insights
Chapter 3. U.S. CRISPR and Cas Genes Genes Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market Driver Analysis
                        3.2.2. Market Restraint Analysis
                    3.3. U.S. CRISPR and Cas Genes Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s Five Forces
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
Chapter 4. U.S. CRISPR and Cas Genes Market Product & Service Estimates & Trend Analysis
                    4.1. U.S. CRISPR and Cas Genes Market Product& Service Dashboard
                    4.2. U.S. CRISPR and Cas Genes Market Product& Service Movement Analysis
                    4.3. U.S. CRISPR and Cas Genes Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    4.4. Product
                        4.4.1. Kits & Enzymes
                            4.4.1.1. Kits & Enzymes Market, 2018 - 2030 (USD Million)
                            4.4.1.2. Vector-based Cas9
                                4.4.1.2.1. Vector-based Cas9 Market, 2018 - 2030 (USD Million
                            4.4.1.3. DNA-free Cas9
                                4.4.1.3.1. DNA-free Cas9 Market, 2018 - 2030 (USD Million)
                        4.4.2. Libraries
                            4.4.2.1. Libraries Market, 2018 - 2030 (USD Million)
                        4.4.3. Design Tool
                            4.4.3.1. Design Tool Market, 2018 - 2030 (USD Million)
                        4.4.4. Antibodies
                            4.4.4.1. Antibodies Market, 2018 - 2030 (USD Million)
                        4.4.5. Others
                            4.4.5.1. Other Products Market, 2018 - 2030 (USD Million
                    4.5. Service
                            4.5.1.1. Service Market, 2018 - 2030 (USD Million)
                        4.5.2. Cell Line Engineering
                            4.5.2.1. Cell Line Engineering Market, 2018 - 2030 (USD Million)
                        4.5.3. gRNA Design
                            4.5.3.1. gRNA Design Market, 2018 - 2030 (USD Million)
                        4.5.4. Microbial Gene Editing
                            4.5.4.1. Microbial Gene Editing Market, 2018 - 2030 (USD Million)
                        4.5.5. DNA Synthesis
                            4.5.5.1. DNA Synthesis Market, 2018 - 2030 (USD Million)
Chapter 5. U.S. CRISPR and Cas Genes Market: Application Estimates & Trend Analysis
                    5.1. U.S. CRISPR and Cas Genes Market Application Dashboard
                    5.2. U.S. CRISPR and Cas Genes Market Application Movement Analysis
                    5.3. U.S. CRISPR and Cas Genes Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    5.4. Biomedical
                        5.4.1. Biomedical Market, 2018 - 2030 (USD Million)
                        5.4.2. Genome Engineering
                            5.4.2.1. Genome Engineering Market, 2018 - 2030 (USD Million)
                        5.4.3. Disease Model Studies
                            5.4.3.1. Disease Model Studies Market, 2018 - 2030 (USD Million)
                        5.4.4. Functional Genomics
                            5.4.4.1. Functional Genomics Market, 2018 - 2030 (USD Million)
                        5.4.5. Epigenetics
                            5.4.5.1. Epigenetics Market, 2018 - 2030 (USD Million)
                        5.4.6. Others
                            5.4.6.1. Other Biomedical Applications Market, 2018 - 2030 (USD Million)
                    5.5. Agricultural
                        5.5.1. Agricultural Market, 2018 - 2030 (USD Million)
Chapter 6. U.S. CRISPR and Cas Genes Market: End-use Estimates & Trend Analysis
                    6.1. U.S. CRISPR and Cas Genes Market End-use Dashboard
                    6.2. U.S. CRISPR and Cas Genes Market End-use Movement Analysis
                    6.3. U.S. CRISPR and Cas Genes Market Size & Forecasts and Trend Analyses, 2018 to 2030
                    6.4. Biotechnology & Pharmaceutical Companies
                        6.4.1. Biotechnology & Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
                    6.5. Academic & Government Research Institutes
                        6.5.1. Academic & Government Research Institutes Market, 2018 - 2030 (USD Million)
                    6.6. Contract Research Organizations (CROs)
                        6.6.1. Contract Research Organizations (CROs) Market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis, By Key Market Participants
                    7.2. Company/Competition Categorization
                    7.3. Vendor Landscape
                        7.3.1. List of key distributors and channel partners
                        7.3.2. Key customers
                        7.3.3. Key company market share analysis, 2023
                            7.3.3.1. Company overview
                            7.3.3.2. Financial performance
                            7.3.3.3. Product benchmarking
                            7.3.3.4. Strategic initiatives
                        7.3.4. Genscript
                            7.3.4.1. Company overview
                            7.3.4.2. Financial performance
                            7.3.4.3. Product benchmarking
                            7.3.4.4. Strategic initiatives
                        7.3.5. Mammoth Biosciences, Inc
                            7.3.5.1. Company overview
                            7.3.5.2. Financial performance
                            7.3.5.3. Product benchmarking
                            7.3.5.4. Strategic initiatives
                        7.3.6. Editas Medicine, Inc.
                            7.3.6.1. Company overview
                            7.3.6.2. Financial performance
                            7.3.6.3. Product benchmarking
                            7.3.6.4. Strategic initiatives
                        7.3.7. Calyxt, Inc.
                            7.3.7.1. Company overview
                            7.3.7.2. Financial performance
                            7.3.7.3. Product benchmarking
                            7.3.7.4. Strategic initiatives
                        7.3.8. Caribou Biosciences, Inc.
                            7.3.8.1. Company overview
                            7.3.8.2. Financial performance
                            7.3.8.3. Product benchmarking
                            7.3.8.4. Strategic initiatives
                        7.3.9. Addgene
                            7.3.9.1. Company overview
                            7.3.9.2. Financial performance
                            7.3.9.3. Product benchmarking
                            7.3.9.4. Strategic initiatives
                        7.3.10. Thermofisher Scientific, Inc
                            7.3.10.1. Company overview
                            7.3.10.2. Financial performance
                            7.3.10.3. Product benchmarking
                            7.3.10.4. Strategic initiatives
                        7.3.11. Integrated DNA Technologies, Inc
                            7.3.11.1. Company overview
                            7.3.11.2. Financial performance
                            7.3.11.3. Product benchmarking
                            7.3.11.4. Strategic initiatives
                        7.3.12. Egenesis
                            7.3.12.1. Company overview
                            7.3.12.2. Financial performance
                            7.3.12.3. Product benchmarking
                            7.3.12.4. Strategic initiatives
                        7.3.13. Danaher Corporation
                            7.3.13.1. Company overview
                            7.3.13.2. Financial performance
                            7.3.13.3. Product benchmarking
                            7.3.13.4. Strategic initiatives
                        7.3.14. Synthego
                            7.3.14.1. Company overview
                            7.3.14.2. Financial performance
                            7.3.14.3. Product benchmarking
                            7.3.14.4. Strategic initiatives
                        7.3.15. Recombinetics, Inc
                            7.3.15.1. Company overview
                            7.3.15.2. Financial performance
                            7.3.15.3. Product benchmarking
                            7.3.15.4. Strategic initiatives
                        7.3.16. Origene Technologies, Inc.
                            7.3.16.1. Company overview
                            7.3.16.2. Financial performance
                            7.3.16.3. Product benchmarking
                            7.3.16.4. Strategic initiatives
                        7.3.17. Inscripta, Inc.
                            7.3.17.1. Company overview
                            7.3.17.2. Financial performance
                            7.3.17.3. Product benchmarking
                            7.3.17.4. Strategic initiatives
                        7.3.18. Intellia Therapeutics, Inc.
                            7.3.18.1. Company overview
                            7.3.18.2. Financial performance
                            7.3.18.3. Product benchmarking
                            7.3.18.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 U.S. CRISPR and Cas Genes Market, By Product&Service 2018 - 2030 (USD Billion)
Table 3 U.S. CRISPR and Cas Genes Market, By Application, 2018 - 2030 (USD Billion)
Table 4 U.S. CRISPR and Cas Genes Market, By End-use, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 CRISPR and Cas Genes genes market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 PESTEL analysis
Fig. 13 Porter’s Five Forces analysis
Fig. 14 U.S. Exosomes Market: Product& service outlook and key takeaways
Fig. 15 U.S. Exosomes Market: Product& service movement analysis & market share 2023 & 2030
Fig. 16 U.S. CRISPR and Cas Genes genes market: Product & service movement analysis
Fig. 17 U.S. CRISPR and Cas Genes genes market, for product, 2018 - 2030 (USD Million)
Fig. 18 U.S. CRISPR and Cas Genes genes market, for kits & enzymes, 2018 - 2030 (USD Million)
Fig. 19 U.S. CRISPR and Cas Genes genes market, for vector-based Cas9, 2018 - 2030 (USD Million)
Fig. 20 U.S. CRISPR and Cas Genes genes market, for DNA-free Cas9, 2018 - 2030 (USD Million)
Fig. 21 U.S. CRISPR and Cas Genes genes market, for libraries, 2018 - 2030 (USD Million)
Fig. 22 U.S. CRISPR and Cas Genes genes market, for design tool, 2018 - 2030 (USD Million)
Fig. 23 U.S. CRISPR and Cas Genes genes market, for antibodies, 2018 - 2030 (USD Million)
Fig. 24 U.S. CRISPR and Cas Genes genes market, for other products, 2018 - 2030 (USD Million)
Fig. 25 U.S. CRISPR and Cas Genes genes market, for service, 2018 - 2030 (USD Million)
Fig. 26 U.S. CRISPR and Cas Genes genes market, for cell line engineering , 2018 - 2030 (USD Million)
Fig. 27 U.S. CRISPR and Cas Genes genes market, for gRNA design , 2018 - 2030 (USD Million)
Fig. 28 U.S. CRISPR and Cas Genes genes market, for microbial gene editing , 2018 - 2030 (USD Million)
Fig. 29 U.S. CRISPR and Cas Genes genes market, for DNA synthesis , 2018 - 2030 (USD Million)
Fig. 30 U.S. Exosomes Market: Application outlook and key takeaways
Fig. 31 U.S. Exosomes Market: Application movement analysis & market share 2023 & 2030
Fig. 32 U.S. CRISPR and Cas Genes genes market: Application movement analysis
Fig. 33 U.S. CRISPR and Cas Genes genes market, for biomedical , 2018 - 2030 (USD Million)
Fig. 34 U.S. CRISPR and Cas Genes genes market, for genome engineering, 2018 - 2030 (USD Million)
Fig. 35 U.S. CRISPR and Cas Genes genes market, for disease model studies, 2018 - 2030 (USD Million)
Fig. 36 U.S. CRISPR and Cas Genes genes market, for functional genomics, 2018 - 2030 (USD Million)
Fig. 37 U.S. CRISPR and Cas Genes genes market, for epigenetics, 2018 - 2030 (USD Million)
Fig. 38 U.S. CRISPR and Cas Genes genes market, for other biomedical applications, 2018 - 2030 (USD Million)
Fig. 39 U.S. CRISPR and Cas Genes genes market, for agricultural , 2018 - 2030 (USD Million)
Fig. 40 U.S. U.S. CRISPR and Cas Genes genes market: End-use t outlook and key takeaways
Fig. 41 U.S. U.S. CRISPR and Cas Genes genes market: End-use movement analysis & market share 2023 & 2030
Fig. 42 U.S. CRISPR and Cas Genes genes market: End-use movement analysis
Fig. 43 U.S. CRISPR and Cas Genes genes market, for biotechnology & pharmaceutical companies, 2018 - 2030 (USD Million)
Fig. 44 U.S. CRISPR and Cas Genes genes market, for academic & government research institutes, 2018 - 2030 (USD Million)
Fig. 45 U.S. CRISPR and Cas Genes genes market, for Contract Research Organizations (CROs), 2018 - 2030 (USD Million)